INTRODUCTION
Despite major progress in unraveling the mechanism of the HIV replication cycle in human T lymphocytes, the role of cells involved in the innate response to HIV and other retroviruses is only now receiving growing attention. Dendritic cells (DCs) serve a key function in host defense, linking innate detection of microbes to activation of pathogen-specific adaptive immune responses (Banchereau et al., 2000) . DCs express cell surface receptors for HIV-1 entry but undergo very limited productive infection as a result of host cell restriction factors (Wu and KewalRamani, 2006) . DCs do, however, facilitate infection of cocultured T-helper cells through a process of trans-enhancement (Cameron et al., 1992; Geijtenbeek et al., 2000) . A cell-intrinsic sensor for HIV-1, cGAS, has the potential to activate the type I interferon response to reverse-transcribed viral DNA in DCs but is not typically engaged owing to a block in reverse transcription mediated by the host dinucleotide triphosphate (dNTP) hydrolase SAMHD1 (Gao et al., 2013; Laguette et al., 2011; Lahaye et al., 2013; Manel et al., 2010) . The virus appears to have evolved to avoid infecting these cells, and it has been proposed that it instead exploits DCs to facilitate rapid infection of a large pool of T cells and, perhaps, to reside in non-replicating reservoirs within DCs (Wu and KewalRamani, 2006) .
trans-enhancement is defined as the capacity of DCs to augment infection of T cells with a minimal HIV inoculum (Cameron et al., 1992; Geijtenbeek et al., 2000) . Binding of the HIV envelope glycoprotein to mannose receptors has been implicated in trans-enhancement, although the C-type lectin DC-SIGN is not absolutely required (Boggiano et al., 2007; Geijtenbeek et al., 2000; Kwon et al., 2002) . Recently, SIGLEC-1 (CD169) was described as an interferon-inducible receptor for HIV-1 transfer from lipopolysaccharide (LPS)-matured DCs to T cells (Izquierdo-Useros et al., 2012) .
trans-enhancement was originally thought to involve classical endocytosis (Kwon et al., 2002) , but it was later found that the internalized virus was still accessible to solvent (i.e., soluble CD4 could inactivate captured HIV) (Cavrois et al., 2007) . This discrepancy was potentially reconciled by the observation that, in mature DCs, HIV-1 is internalized in a tetraspaninrich compartment (containing CD81), called the ''invaginated pocket,'' which is still accessible to solvent but is topologically distinct from the cell membrane (Yu et al., 2008) .
To gain more insight into the mechanism of trans-enhancement, we performed a short hairpin RNA (shRNA) screen in immature human primary monocyte-derived DCs (MDDCs). We focused on several hundred genes involved in organelle and membrane trafficking to identify those that impact HIV-1 transfer, and identified and validated the function of tetraspanin 7 (TSPAN7) and dynamin 2 (DNM2). TSPAN7 is localized at the plasma membrane and has a critical role in neurite outgrowth (Bassani et al., 2012) . The large GTPase DNM2 plays a key role in endocytosis (Ferguson and De Camilli, 2012) and is recruited to the neck of coated pits where it can assemble into a collar structure to mediate membrane fission. More recently, DNM2 was described as an important regulator at the interface between the membrane and the dynamic actin cytoskeleton, modulating actin nucleation and promoting the stability of the actin filament network (Ferguson and De Camilli, 2012; Gu et al., 2010; Lee and De Camilli, 2002; Orth et al., 2002) . We show here that during HIV-1 transfer from DCs, TSPAN7 and DNM2 control nucleation and cortical stabilization of actin, which limits HIV-1 endocytosis and maintains the virus on dendrites for efficient transfer to T lymphocytes.
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RESULTS
RNAi Screen for Genes Involved in DC to T Cell HIV Transfer To identify genes involved in the transfer of HIV-1 from DCs to T lymphocytes, we performed an shRNA screen, in human primary-monocyte-derived dendritic cells (MDDCs), of 455 genes (4 or 5 shRNAs per gene) whose products are involved in organelle and membrane trafficking (Table S1 ). We used Vpx-containing SIV virus-like particles to achieve highly efficient transduction of MDDCs with lentiviral vectors encoding the shRNAs. To assess the transfer of HIV-1 from MDDCs to T cells, we cocultured transduced MDDCs at a ratio of 1:1 with autologous CD4 + T cells activated with IL-2 and PHA ( Figure 1A ). The cultures were infected with a replication-competent CXCR4-tropic HIV-1 encoding GFP in place of Nef, and the proportion of infected GFP + CD4 + T cells was assessed by flow cytometry after 2 days. There was no detectable replication of HIV-1 in MDDCs, and presence or absence of Nef had no impact on viral transfer from MDDCs to T cells (M.M.M., unpublished data). Several controls were included for each donor: the PLK0.1 vector with a scrambled shRNA, empty vector, or transduction without vector, allowing assessment of nonspecific effects due to transduction and/or processing of shRNAs. The variation of transfer among the controls was lower than 5% on average, with a maximal variation never reaching >20% (Figures S1A and S1B). Among the targeted genes, we found a >30% decrease in HIV-1 transfer with at least two shRNAs for 43 genes and with one shRNA for 38 genes. Targeting of another 25 genes with at least two shRNAs per gene and of 28 genes with one shRNA increased transfer by at least 30% ( Figure 1B ; Table S1 ). Among the hits for which we observed reduced HIV-1 transfer, there was enrichment for genes involved in actin nucleation (18 genes out of 81) and/or membrane protrusions (10 genes out of 81) ( Figure S1C ), including four out of the seven subunits of the ARP2/3 complex. Direct regulators of this complex, including WASP and CDC42 (Rohatgi et al., 1999) , also scored in the assay, as did CFL1, which promotes debranching of actin filaments and whose knockdown enhanced HIV-1 transfer (Martin et al., 2006) . Proteins whose functions are mainly in formation and stabilization of cortical actin, including ARL13B (Casalou et al., 2014) and DNM2 (Ferguson and De Camilli, 2012; Gu et al., 2010; Lee and De Camilli, 2002; Menon et al., 2014; Orth et al., 2002) , were similarly required for efficient HIV-1 transfer.
Hits that resulted in increased HIV-1 transfer were enriched for genes (24 out of 53) involved in several endocytic pathways (Figure S1D ). These included genes involved in clathrin-mediated endocytosis (CME) such as those encoding clathrin heavy and light chain (CLTC, CLTB and CLTA); members of the clathrinassociated protein complexes AP-1 (AP1M1; AP1G1), AP-2 (AP2M1), and AP-4 (AP4M1); and myosin Va (MYO5A), an actin-based motor protein (Boettner et al., 2012; Doherty and McMahon, 2009) . Genes encoding molecules involved in caveolin-mediated endocytosis included CAV3, CAV1, and FLOT1 (Glebov et al., 2006) . Together, these results thus suggested roles for actin nucleation and endocytosis in enhancing or limiting HIV-1 transfer, respectively.
TSPAN7 Is Required for HIV-1 Transfer and Dendrite Formation
Among the genes whose knockdown resulted in robust decrease in transfer ( Figure 1B ), TSPAN7 caught our attention, as it is a yet uncharacterized member of the tetraspanin family, for which several members (CD9, CD63, CD81, and CD82) were reported to be involved in HIV-1 cell-to-cell transfer and/ or trafficking (Garcia et al., 2005) . We confirmed, using blood from multiple donors, a reproducible nearly 50% decrease of HIV-1 transfer using shRNA sequences targeting different regions of TSPAN7 as compared to scrambled shRNA (Figures 2A and 2B) (Bassani et al., 2012) . The efficiency and specificity of TSPAN7 knockdown were assessed by both qPCR and immunoblot ( Figures S2A and S2B) . Additionally, TSPAN7 expression was induced during differentiation of MDDCs from monocytes in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-4 and was correlated with appearance of dendrites ( Figure S2C ; M.M.M., unpublished data).
By confocal microscopy, there was a marked change in DC morphology resulting from reduced TSPAN7 expression. Phalloidin staining revealed a loss of long and thin actin-rich membrane extensions, or dendrites, upon TSPAN7 knockdown ( Figure 2C ). Transmission and three-dimensional scanning electron microscopy (3D-SEM) analysis confirmed this effect and showed that a decrease in TSPAN7 expression shifted the balance from dendrites toward formation of short and large blebs of the plasma membrane (Figures 2D and 2E ; Movie S1).
TSPAN7 Prevents HIV-1 Redistribution from Dendrites to Macropinosomes
To study localization of incoming HIV-1 particles by confocal microscopy, we exposed MDDCs to replication-competent virus containing a Gag-internal GFP (iGFP), as previously described (Hü bner et al., 2007) . Upon TSPAN7 shRNA knockdown, the loss of dendrites was accompanied by redistribution of HIV-1 particles from dendrites to cytosolic compartments, observed by both confocal ( Figure 3A ) and transmission electron microscopy ( Figures 3B and 3C ). By comparison, electron microscopy of control co-cultures revealed synaptic clefts with numerous HIV-1 particles in very close vicinity of dendrites, but Results of the shRNA screen, displayed as the percent change in proportion of infected T cells relative to the proportion observed with scrambled control shRNAs. For each shRNA, the average of two biological replicates is displayed as a red dot and the SD is depicted by a blue line. The dashed red line symbolizes an arbitrary cutoff of ±20% for nonspecific variation in HIV-1 transfer, and the green dashed line (±30%) demarcates hits. For each gene, the sum of the effect of all shRNAs on trans-enhancement was calculated and the average effect per shRNA was used as a ranking score for the hits (Table S1 ). Potential hits are shown in heatmaps depending on the presence of at least two shRNAs (**) or one shRNA (*) among the hits. See also Figure S1 and Table S1 . HIV-1-loaded vesicles were abundant only in the infected T cells ( Figure S2D ). Aggregates of HIV-1 were present in large vesicles (between 0.3 and 1 mM) that also internalized dextran, a marker of macropinosome-like vesicles (94.8% ± 5% colocalization) (Wang et al., 2014 ) ( Figures 3B, 3D , and S2E), contained MHC class II and Rab7 (97.5% ± 2.9% and 93.38% ± 5% colocalization respectively), a marker for late endosomes, and were surrounded by the tetraspanin CD81(25.8% ± 9.3% colocalization), which is usually localized at the plasma membrane and in endosomes ( Figure 3D ). By electron microscopy, we were able to observe HIV-1 internalization through mechanisms resembling bleb retraction ( Figure 3B , bottom). There was no co-localization of HIV-1 aggregates with clathrin-or caveolin-positive vesicles (1.2% ± 0.9% and 1% ± 0.6% colocalization, respectively) or with markers of early endosomes (EEA1) and lysosomes (Lamp2) (6% ± 6.4% and 3.5% ± 5.3% colocalization, respectively) ( Figure S2F ; M.M.M., unpublished data). Uptake by MDDCs of both dextran and HIV-1 particles was markedly enhanced upon knockdown of TSPAN7 , consistent with increased macropinocytosis activity. Together, these observations suggest that the decrease in HIV-1 transfer from MDDCs to T cells is linked to the loss of actin-rich dendrites and to an increase in virus uptake in macropinosomes.
Inhibition of ARP2/3 Mimics TSPAN7 Phenotypes
The ARP2/3 complex performs critical functions in formation of membrane protrusions and actin-rich structures, catalyzing actin filament nucleation required for assembly of actin filament networks (Goley and Welch, 2006) . Treatment of MDDCs with CK666 and CK869, specific inhibitors of ARP2/3-mediated actin nucleation, reduced viral transfer ( Figures 4A, 4B , and S3A) (Hetrick et al., 2013) . The drugs had no effect on cell-free infection of T cells with HIV-1, supporting a specific role for actin nucleation in DCs during viral transfer ( Figure S3A ). The decrease in transfer was accompanied by loss of actin-rich dendrites ( Figures 4C and  4D ), increased HIV-1 capture (Figures 4E and 4F) , and increased virion uptake in macropinocytic-like vesicles (M.M.M., unpublished data). There was a global increase of macropinocytosislike endocytic processes upon inhibition of actin nucleation, with accumulation of dextran in MDDCs (Figures S3B-S3D ). There was no synergistic or additive effect on HIV-1 transfer when ARP2/3 was inhibited in MDDCs treated with TSPAN7 shRNAs (Figures 4G and 4H) .
Dendritic to T cell contact is required for HIV-1 trans-enhancement (McDonald et al., 2003) . There was no change in the number of contacts between MDDCs and T cells upon inhibition of ARP2/3-mediated actin nucleation or TSPAN7 knockdown, as assessed by flow cytometry analysis of doublet formation (Figure S3E) and confocal microscopy analysis, in which conjugate formation was defined as contact between plasma membranes and enrichment of actin staining at the zone of contact ( Figures  S3F and S3G) . However, the nature of the contacts was different, with a shift from dendrite-mediated contact to tight contact between plasma membranes (Figures S3F and S3G) . No differences in surface expression of molecules previously implicated in DC-T cell interactions and HIV-1 transfer, including LFA-1, ICAM-1, SIGLEC-1, DC-SIGN, and DC-IR, were detected by flow cytometry analysis (M.M.M., unpublished data). Thus, decreased HIV-1 transfer following inhibition of actin nucleation was most likely due to the loss of dendrites and an accumulation of HIV-1 in macropinocytic structures and not to reduced contact of MDDCs with T cells.
Requirement for DNM2 in HIV-1 Transfer Independent of Dendrite Formation
Dynamin 2 (DNM2), a strong hit in the shRNA screen (Figures 1,  5A , and 5B), has been implicated in nucleation and stabilization of actin networks (Gu et al., 2010; Lee and De Camilli, 2002; Menon et al., 2014; Orth et al., 2002) . The specificity of DNM2 knockdown and function was validated by qPCR ( Figure S4A ) and by use of the dynamin-specific inhibitors dynasore and Dyn V-32 (Yamada et al., 2009 ) that inhibited HIV-1 infection of T cells only when MDDCs were present in the co-culture ( Figures  5C and S4B ). After DNM2 knockdown, there was a 3-fold increase in HIV-1 capture ( Figures 5D and S4C ) and increased dextran internalization by MDDCs, similar to what was observed with TSPAN7 knockdown (Figures S4D and S4E ). There was no difference in contacts between T cells and MDDCs ( Figure S4F ) or in surface expression of LFA-1, ICAM-1, SIGLEC-1, DC-IR, and DC-SIGN (M.M.M., unpublished data). HIV-1 was relocalized from dendrites to aggregates (Figures 5E and 5F) that were also positive for dextran uptake, Rab7, HLA-DP-DQ-DR, and CD81 ( Figure 5G ) (89.4% ± 6%, 92.1% ± 3.4%, 95.1% ± 3.9%, and 21.1% ± 5.1% colocalization, respectively) but differed from clathrin-or caveolae-associated vesicles, early endosomes, and lysosomes (4.7% ± 1.4%, 8.9% ± 7.5%, 1.8% ± 1.6%, and 1.4% ± 1.8% colocalization respectively) (Figure S4G) . No synergy or additive effects were noticed when cells were treated with CK666, dynasore, or a combination of both drugs, suggesting that they inhibit HIV-1 transfer through the same pathway ( Figure 5H ). In contrast to inhibition of TSPAN7 expression, there was no noticeable reduction of actin-rich dendrites, as assessed by confocal microscopy, after blockade of DNM2 expression (Figure 5E ). Electron microscopy revealed an unusual mix of dendrites and blebs at the surface of the dendritic cells ( Figure S4H , left), with large vesicles (from 0.3 to 1 mM) that are likely macropinosomes containing HIV-1 particles ( Figure S4H, right) .
Although TSPAN7 and DNM2 differed in their requirement for dendrite formation and/or maintenance, there was disruption in the continuity of phalloidin staining beneath the plasma membrane when either molecule was knocked down, as shown by analysis and measurement of multiple z stack images ( Figure S5) . Disruption of the actin filaments following inhibition of TSPAN7 or DNM2 expression was associated with mislocalization of HIV-1 particles beyond the cortical region adjacent to the plasma membrane ( Figure S5A ). Together, these findings suggest that TSPAN7 and DNM2 are critical for establishment and/or maintenance of a stable cortical actin barrier that limits HIV-1 uptake by dendritic cells.
Inhibition of Macropinocytosis Can Rescue HIV-1 Transfer upon DNM2 Knockdown in MDDCs
To assess the impact of HIV-1 internalization on its transfer to T cells, we treated MDDCs with inhibitors of the main endocytic pathways, before co-culturing them with HIV-1 and T cells. We established optimal conditions to inhibit clathrin-or caveolaemediated endocytosis and macropinocytosis in MDDCs by respectively using chlorpromazine (CPZ), nystatin, or rottlerin ( Figures S6A and S6B) (Ivanov, 2008; Sarkar et al., 2005) . We observed enhanced HIV-1 transfer with all inhibitors, but most prominently with rottlerin ( Figures 6A and S6C) . The increase in HIV-1 transfer was accompanied by decreased HIV-1 internalization, most marked in the presence of rottlerin, as monitored by flow cytometry after p24 intracellular staining ( Figures 6B  and 6C ). Increased HIV-1 transfer was also observed in the presence of other drugs (IPA-3 [10 mM], NEIPA [10 mM], and antimycin A1 [10 mM]) that block macropinocytosis ( Figures S6D and S6E) .
These results suggested that uptake of HIV-1 by way of multiple pathways can reduce transfer to T cells. We found that, indeed, MDDCs can internalize small numbers of HIV-1 particles in vesicles containing either clathrin, caveolin, or, more frequently, internalized fluorescently labeled dextran (26.9% ± 6.8%, 16.75% ± 5.61%, and 53.81% ± 12.5% colocalization, respectively) ( Figure S6F ). Macropinocytic events, depicted by plasma membrane ruffles folding back on HIV-1, were visible by electron microscopy ( Figure S6G ). HIV uptake by MDDCs thus appears to involve multiple mechanisms, although macropinocytosis is favored. The magnitude of this uptake differs from the much more prominent virion internalization observed almost exclusively in dextran-containing compartments following inhibition of TSPAN7 or DNM2 expression.
We next examined whether accumulation of HIV-1 in macropinosome-like vesicles, observed after TSPAN7 and DNM2 knockdown, contributes to decreasing HIV-1 transfer by lowering availability of HIV-1 at the plasma membrane. MDDCs in which TSPAN7 or DNM2 were knocked down were incubated with CPZ, rottlerin or nystatin and HIV-1 transfer to T cells was assessed. The endocytosis inhibitors had no apparent effect on inhibition of transfer following TSPAN7 knockdown, despite their enhancement of transfer in control shRNA-treated MDDCs (Figures 6D and 6E) . However, inhibition of macropinocytosis specifically restored HIV-1 transfer after knockdown of DNM2, to a level similar in magnitude to that observed in control shRNAtreated MDDCs (Figures 6D and 6E) . Thus, inhibition of HIV-1 uptake by macropinocytosis overcomes dependency on DNM2, but not TSPAN7, for efficient HIV-1 transfer to T cells. 
Inhibition of Actomyosin Contraction Rescues Dendrite Formation and HIV-1 Transfer
As inhibition of actin nucleation leads to the replacement of actin-rich dendrites with blebs, we next wondered what would be the impact on HIV-1 transfer if we blocked bleb formation. For this purpose, we inhibited non-muscle myosin II ATPase activity in MDDCs using the specific inhibitor blebbistatin (Straight et al., 2003) . This inhibition resulted in a dose-dependent increase in HIV-1 transfer, following 2 hr treatment of wild-type MDDCs with the active enantiomer of blebbistatin ( Figures 7A  and S7A ). Inhibiting actomyosin contractility also rescued HIV-1 transfer from MDDCs in which TSPAN7 or DNM2 had been knocked down or that were subsequently treated with CK666 or dynasore ( Figures 7A and S7A ). We observed a very strong correlation (Pearson's correlation coefficient = 0.94) between the level of inhibition of HIV-1 transfer due to disruption of actin nucleation and the ability of blebbistatin to rescue and increase HIV-1 transfer ( Figure S7B ). Of note, treatment of T cells alone with either blebbistatin enantiomer had no effect on their infection with HIV-1 ( Figure S7C ). The blebbistatin-mediated increase or rescue of HIV-1 transfer was linked to an impressive increase or restoration in formation of filopodia and actin-rich dendrites ( Figure 7B , left and middle). This was accompanied by increased or restored localization of HIV-1 on actin-rich dendrites (quantified in Figure 7C ). Inhibition of DNM2 function did not prevent the increase in filopodia and ''extended'' actin-rich dendrites, but it limited the maintenance of HIV-1 on the ''extended'' dendrites ( Figure 7B , right, and Figure 7C) . By comparison, although inhibition of macropinocytosis with rottlerin attenuated HIV-1 internalization in multiple conditions (scramble, TSPAN7, or DNM2 shRNA knockdown), it did not enhance actin nucleation and formation of actin-rich dendrites ( Figures 7B and 7C) . Finally, active blebbistatin reduced the macropinocytosis-dependent HIV-1 and dextran internalization following TSPAN7 or DNM2 knockdown ( Figures 7D and S7D ).
In conclusion, inhibition of actomyosin contraction compensates for defective actin nucleation and cortical actin stability in MDDCs and thus facilitates HIV-1 localization on extracellular dendrites and concomitant viral transfer to T cells.
DISCUSSION
Although the phenomenon of trans-enhancement has been known for over two decades, studies to date have mainly focused on which DC receptors are involved and whether virions are internalized prior to being handed off to T cells. Actin-rich sheet-like membrane extensions dependent on Cdc42 were previously described as critical for HIV-1 transfer in immature MDDCs (Nikolic et al., 2011) . Using a robust quantitative genetic screen, we were able to identify, with high confidence, that actin nucleation and an intact cortical actin cytoskeleton are required to maintain HIV-1 association with dendrites and prevent engulfment of virus into macropinocytic vesicles. These results reinforce the growing consensus that HIV-1 is transmitted directly from the cell surface, rather than through an obligate endocytic pathway (Cavrois et al., 2008; Do et al., 2014; Yu et al., 2008) .
TSPAN7 and Regulation of Actin Nucleation
Tetraspanin family members are involved in multiple aspects of cell biology and physiology, including cell motility, signaling, morphology, neurite outgrowth, viral entry, and tumorigenesis (Charrin et al., 2014) . In cultured hippocampal neurons, TSPAN7 is required for filopodia and dendritic spine formation and stabilization, a role that is consistent with the subcellular phenotypes associated with the characterized X-linked mental retardation pathology, due to mutations in TSPAN7 (Bassani et al., 2012; Zemni et al., 2000) . Even though TSPAN7 expression is not as high in MDDCs as in brain, its expression was induced during monocyte to DC differentiation and correlated with the formation of dendrites. We found that inhibitors of the ARP2/3 complex phenocopied the TSPAN7 knockdown in MDDCs. As dendritic spine formation is dependent on actin nucleation, a role for TSPAN7 in regulating the actin cytoskeleton was proposed. Accordingly, the C-terminal tail of TSPAN7 binds the PDZ domain of PICK1 (Bassani et al., 2012) , a molecule that interacts with ARP2/3 and F-actin filaments to inhibit actin nucleation (Rocca et al., 2008) . Thus, in DCs, TSPAN7 may sequester PICK1 to prevent its inhibition of ARP2/3. Another mode of action of TSPAN7 could be through interactions with phosphatidylinositol 4-kinase (PI4K) (Yauch and Hemler, 2000) and b1-integrin (Bassani et al., 2012; Berditchevski, 2001) , which regulate the actin cytoskeleton through biosynthesis of phosphatidylinositol 4,5-bisphosphate and recruitment of ARP2/3 complex-interacting proteins to the vicinity of plasma membrane phosphoinositides (Berditchevski, 2001; Hilpelä et al., 2004) .
DNM2 and Regulation of Cortical Actin
DNM2 is a large GTPase, which can self-assemble into higher-order structures to promote endocytosis by stimulating the fission of budding vesicles upon GTP hydrolysis (Doherty and McMahon, (legend continued on next page)
2009; Ferguson and De Camilli, 2012) . DNM2 is also recognized as a regulator of the actin network and has been found co-localizing with actin-rich structures such as podosomes, actin comet tails, phagocytic cups, dynamic cortical ruffles, and lamellipodia (Ferguson and De Camilli, 2012; Gu et al., 2010) . Within lamellipodia, DNM2 regulates the spatiotemporal distribution of a-actinin and cortactin, actin-binding proteins that influence the actin network (Menon et al., 2014) . DNM2 also binds directly to F-actin filaments and aligns them into bundles and participates in the elongation of actin filaments by releasing the actin capping protein gelsolin (Gu et al., 2010) . Interestingly, it has been reported that DNM2-depleted cells retain their capacity to form membrane protrusions even though there is a reduction in the dense network of branched cortical actin (Menon et al., 2014) . This is consistent with our observation that, in MDDCs, there was retention of actin-rich dendrites despite the loss of a continuous barrier of cortical actin upon knockdown of DNM2.
Regulation of HIV-1 Internalization by Macropinocytosis
Our results show that, in MDDCs, extension of membrane protrusions and endocytosis are tightly linked and inversely correlated, based on their dependency on actin nucleation and cortical actin. Upon disruption of the cortical actin filament network, we observed a selective increase in macropinocytosis-mediated solute uptake and sequestration of HIV-1 particles in large intracellular vesicles, also enriched for MHC class II. Targeting of this pathway may thus improve presentation of HIV antigens to T cells, restricting viral dissemination. The cortical actin network creates tension that inhibits endocytosis (Gauthier et al., 2012; Kaur et al., 2014) , and debranching and subsequent actin remodeling and/or depolymerization are required for membrane bending and vesicle morphogenesis during endocytosis (Martin et al., 2006) . Our results in MDDCs are consistent with such a role. A form of macropinocytosis that involves blebs, which are largely devoid of branched and polymerized actin, has been described for vaccinia virus, whose internalization has been linked to bleb retraction (Mercer and Helenius, 2008) . TSPAN7 knockdown or CK666 treatment induced a switch from actin-rich protrusions to blebs. By inhibiting bleb formation using blebbistatin we demonstrated that increased internalization of HIV-1 occurs through bleb retraction, following disruption of actin nucleation. Treatment of MDDCs with blebbistatin also led to a marked increase in an ''extended'' network of actin-rich dendrites that were adorned with HIV-1 particles in a context of intact actin nucleation ( Figure S7E ). The concomitant increase in HIV-1 transfer reinforces the importance of viral maintenance on actin-rich dendrites in this process.
Bleb formation, which is driven by actomyosin contraction (Ridley, 2011) , is antagonized in a dynamic and finely regulated manner by Arp2/3 activity that controls the cellular actin cortex and cortical tension (Bergert et al., 2012) . Growth cone collapse, which occurs in the absence of protrusive forces derived from actin nucleation, can be rescued by inhibition of contractile forces (actomyosin) produced by nonmuscle myosin II (Yang et al., 2012) . Our data suggest that the same mechanism is utilized during formation of actin-rich dendrites in immature MDDCs ( Figure S7E) . Results with DNM2 knockdown, which reduced HIV-1 transfer and was reversed by inhibition of macropinocytosis, suggest that DNM2 functions independently of the ARP2/3 complex to control cortical actin stability ( Figure S7E ).
Dendritic Cell Function in HIV Pathogenesis
DCs are likely the first cells to encounter and capture HIV-1 during viral transmission. By localizing to the surface of actin-rich filopodia-like structures, HIV-1 may increase its likelihood of encountering CD4 + T cells. By failing to efficiently replicate in DCs, HIV-1 has the potential to avoid innate immune detection (Manel et al., 2010) and instead exploit DCs to rapidly and efficiently infect CD4 + T cells through trans-enhancement. Such a model was recently supported by in vivo evidence for a contribution of trans-infection to retroviral spread in humanized mice (Sewald et al., 2015) . Our genetic approach is a first step toward a better understanding of the molecular and cell biological aspects of HIV-1 transmission between DCs and T lymphocytes, which is needed to evaluate the importance of this process in animal models and, eventually, in infected individuals. The genes identified in this study may thus serve as targets for limiting early HIV-1 transfer and propagation.
EXPERIMENTAL PROCEDURES
Transduction and shRNA Screen Blood monocytes were plated at 1 3 10 5 cells per well in 100 ml medium with cytokines (human GM-CSF and human IL-4) and were transduced with 50 ml of SIVmac VLP/Vpx (Mangeot et al., 2002) in the presence of 5 mg/ml polybrene and 50 ml (10 7 IU/ml) viral supernatant containing each shRNA from a human vesicular and membrane trafficking library (Broad Institute [SIGMA]; Moffat et al., 2006) . Approximately 50,000 transduced MDDCs were recovered per well after 4 days of differentiation and were used for transfer experiments in co-cultures with autologous T cells and X4-HIV-1 GFP. See also Supplemental Experimental Procedures.
trans-enhancement and Flow Cytometry Analysis
After 4 days of stimulation with human GM-CSF (50 ng/ml) and human IL-4 (10 ng/ml), 50,000 MDDCs (1 million/ml) were mixed with 50,000 (1 million/ ml) autologous CD4 + T cells (activated for 4 days in the presence of phytohemagglutinin A [PHA-L 2 mg/ml] + IL-2 [10 IU/ml]) and 150 ml X4-tropic HIV-1 encoding GFP (50 ng p24 GAG , quantified by ELISA) per well in 96-well round-bottom plates. Media was replaced after 24 hr and GFP expression in T cells analyzed by flow cytometry another 24 hr later. For flow cytometry analysis, cells were stained with anti-CD3 A700 (for T cells), anti-DC-SIGN PE (for MDDCs), and DAPI for live/dead gating. CountBright Absolute Counting Beads (Life Technologies) were used in each sample to assess changes in cell number. In some cases, BD cytofix/cytoperm buffer and fixation protocol was used to detect intracellular P24 staining in both MDDCs and T cells during transfer and/or capture experiments. 
Confocal Microscopy
Microscopy was performed on a Zeiss 710 confocal with 405-, 488-, 543-, and 633-nm lasers, a 633 numerical aperture 1.40 lens, and the pinhole set to 1 Airy unit as defined by Zeiss. Sequential scanning was used to assure no spillover of channels. Z series were taken at intervals of 400 nm.
Electron Microscopy
Cells were fixed in 0.1 M sodium cacodylate buffer (pH 7.2) containing 2.5% glutaraldehyde and 2% paraformaldehyde for 2 hr and post-fixed with 1% osmium tetroxide for 1.5 hr at room temperature, then processed in a standard manner and embedded in EMbed 812 (Electron Microscopy Sciences). Ultrathin sections (60 nm) were mounted on 200-mesh thin-bar copper grids, stained with uranyl acetate and lead citrate, examined using Philips CM-12 electron microscope (FEI) and photographed with a Gatan (4k 3 2.7k) digital camera (Gatan).
HIV-1 and Dextran Capture Experiments
Four days after transduction with shRNAs, MDDCs were mixed with X4-HIV-GFP using the same conditions as with trans-infection experiments but without T cells. After 4 hr co-culture, MDDCs were washed in cold PBS to remove unbound HIV-1 and RNA was extracted. After reverse transcription, the amount of HIV-1 RNA was detected by qRT-PCR with primers for GFP (encoded inside the HIV genome) and normalized to GAPDH. For dextran capture experiments, MDDCs were loaded with 100 mg/ml of dextran molecules of various size for 30 min, washed extensively with cold PBS, and analyzed by flow cytometry.
Statistics
Unless otherwise specified, statistical analyses were done using the Holm-Sidak multiple comparison test following one-way ANOVA (NS, not significant; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001). For most experiments, two different human blood donors were used and the average of triplicates and SD were calculated for each blood donor. 
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